The Binary Endocardial Appearance Is a Poor Discriminator of Anderson-Fabry Disease From Familial Hypertrophic Cardiomyopathy

Journal of the American College of Cardiology

Volumn 51, Issue 21, 2008, Pages 2058-2061

  Kounas, Stavros ^a   Demetrescu, Camelia ^a   Pantazis, Antonios A ^a   Keren, Andre ^b   Lee, Philip J ^c   Hughes, Derralynn ^d   Mehta, Atul ^d   Elliott, Perry Mark ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^d ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DATA BASE; ENDOCARDIUM; FABRY DISEASE; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; FEMALE; HEART LEFT VENTRICLE ENDSYSTOLIC SIZE; HEART LEFT VENTRICLE SIZE; HEART VENTRICLE HYPERTROPHY; HUMAN; MALE; PATIENT SELECTION; PRIORITY JOURNAL; RANDOMIZATION; SCREENING TEST; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

ADULT; AGED; CARDIOMYOPATHY, HYPERTROPHIC, FAMILIAL; DIAGNOSIS, DIFFERENTIAL; DOUBLE-BLIND METHOD; ECHOCARDIOGRAPHY; ENDOCARDIUM; FABRY DISEASE; FEMALE; HEART VENTRICLES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; OBSERVER VARIATION; SENSITIVITY AND SPECIFICITY;

EID: 43549105611     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2008.02.046     Document Type: Article

References (12)

1. Maron B.J., McKenna W.J., Danielson G.K., et al. ACC/ESC clinical expert consensus document on hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines (Committee to Develop an Expert Consensus Document on Hypertrophic Cardiomyopathy). J Am Coll Cardiol 42 (2003) 1687-1713
2. Nakao S., Takenaka T., Maeda M., et al. An atypical variant of Fabry's disease in men with left ventricular hypertrophy. N Engl J Med 333 (1995) 288-293
3. Sachdev B., Takenaka T., Teraguchi H., et al. Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy. Circulation 105 (2002) 1407-1411
4. Pieroni M., Chimenti C., De Cobelli F., et al. Fabry's disease cardiomyopathy: echocardiographic detection of endomyocardial glycosphingolipid compartmentalization. J Am Coll Cardiol 47 (2006) 1663-1671
5. McKenna W.J., Spirito P., Desnos M., Dubourg O., and Komajda M. Experience from clinical genetics in hypertrophic cardiomyopathy: proposal for new diagnostic criteria in adult members of affected families. Heart 77 (1997) 130-132
6. Schiller N.B., Shah P.M., Crawford M., et al. Subcommittee on Quantitation of Two-Dimensional Echocardiograms, American Society of Echocardiography Committee on Standards. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 2 (1989) 358-367
7. Schiffmann R., Kopp J.B., Austin H.A., et al. Enzyme replacement therapy in Fabry disease: a randomized controlled trial. JAMA 285 (2001) 2743-2749
8. Beck M., Ricci R., Widmer U., et al. Fabry disease: overall effects of agalsidase alfa treatment. Eur J Clin Invest 34 (2004) 838-844
9. Linthorst G.E., Vedder A.C., Aerts J.M., and Hollak C.E. Screening for Fabry disease using whole blood spots fails to identify one-third of female carriers. Clin Chim Acta 353 (2005) 201-203
10. Linhart A., Palecek T., Bultas J., et al. New insights in cardiac structural changes in patients with Fabry's disease. Am Heart J 139 (2000) 1101-1108
11. Weidemann F., Breunig F., Beer M., et al. The variation of morphological and functional cardiac manifestation in Fabry disease: potential implications for the time course of the disease. Eur Heart J 26 (2005) 1221-1227
12. Ommen S.R., Nishimura R.A., and Edwards W.D. Fabry disease: a mimic for obstructive hypertrophic cardiomyopathy?. Heart 89 (2003) 929-930